NCT01700413View on ClinicalTrials.gov

Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

April 30, 2015

Conditions
Di Novo Acute Myeloid Leukemia
Interventions
DRUG

Idarubicin

Trial Locations (5)

46010

Hospital Clínico Universitario de Valencia, Valencia

08916

Hospital Universitari Germans Trias I Pujol de Badalona, Badalona

08025

Hospital de La Santa Creu I Sant Pau, Barcelona

08035

Hospitals Vall D'Hebron, Barcelona

08036

Hospital Clinic I Provincial de Barcelona, Barcelona

All Listed Sponsors
collaborator

Ministry of Health, Spain

OTHER_GOV

collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

lead

Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias

OTHER

NCT01700413 - Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter